Thu, Apr 24, 2014, 11:26 AM EDT - U.S. Markets close in 4 hrs 34 mins

Recent

% | $
Quotes you view appear here for quick access.

Curis, Inc. Message Board

  • docihi docihi Aug 22, 2012 9:45 AM Flag

    michael gray confirmed via email

    that both curis and genentech have no control over release of information and time of study completion for clinical trials that are being run by third parties. most of us knew this. this would include almost all of the trials, including the triple comb. pancreatic trial due for an est primary completion date of 12/2012, which is being run at sidney kimmel. according to the history of changes, as of 3/26/12, sidney kimmel at jhu was still recruiting.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Thanks for the update. You will need to save this post because in a day, week or month you will have the same a holes post how management isn't at work, they never respond, why don't they release information on the ongoing trials, they are useless and on and on. I believe it is actually just one poster under various aliases but we all know who he is as he is so transparent. Even when presented with facts that dispute his ridiculous opinions he then ignores the facts and spouts off his BS as if that is the real fact. Thanks again for sharing and the price will come back to reasonable values sooner or later.

    • Thanks dochi....good information, and would like to thank the shorts for providing shares at a lower rate :).

 
CRIS
2.32+0.01(+0.43%)11:23 AMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.